Corient Private Wealth
CDNA icon

Corient Private Wealth’s CareDx CDNA Stock Holding History

Corient Private Wealth’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697K Buy
+24,450
New +$532K ﹤0.01% 2013

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's CDNA Position: Q2 2026 in Review

Corient Private Wealth opened a new position in CareDx (CDNA) in Q2 2026: 24,450 shares worth $697K. The stake represents ﹤0.01% of the portfolio and ranks #2013 among its holdings.

227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Corient Private Wealth held 24,450 shares of CareDx worth $697K as of Q2 2026.
  • CareDx was a new Corient Private Wealth position in Q2 2026.
  • CareDx made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2013 holding.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.